20
Participants
Start Date
October 31, 2025
Primary Completion Date
October 31, 2026
Study Completion Date
April 30, 2027
Novalung ultimate kit, Xenios 2.0, and MultiSupport Ground (MSG)
Patients will receive ECLS treatment using the Novalung ultimate kit, Xenios 2.0, and MultiSupport Ground (MSG) during ground-based inter-hospital patient transport and/ or stationary treatment according to their intended use and local standards/ requirements.
Collaborators (1)
Alcedis GmbH
INDUSTRY
Xenios AG
INDUSTRY